TR201903659T4 - (Hetero) aryl cyclopropylamine compounds as LSD1 inhibitors. - Google Patents
(Hetero) aryl cyclopropylamine compounds as LSD1 inhibitors. Download PDFInfo
- Publication number
- TR201903659T4 TR201903659T4 TR2019/03659T TR201903659T TR201903659T4 TR 201903659 T4 TR201903659 T4 TR 201903659T4 TR 2019/03659 T TR2019/03659 T TR 2019/03659T TR 201903659 T TR201903659 T TR 201903659T TR 201903659 T4 TR201903659 T4 TR 201903659T4
- Authority
- TR
- Turkey
- Prior art keywords
- hetero
- lsd1 inhibitors
- compounds
- aryl cyclopropylamine
- cyclopropylamine compounds
- Prior art date
Links
- -1 aryl cyclopropylamine compounds Chemical class 0.000 title abstract 2
- 125000005842 heteroatom Chemical group 0.000 title abstract 2
- 229940123628 Lysine (K)-specific demethylase 1A inhibitor Drugs 0.000 title 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Buluş, özel olarak burada tarif edildiği ve tanımlandığı üzere formül I'in bileşiklerini içeren, (hetero)aril siklopropilamin bileşikleri ve bunların, örneğin, kanserin, bir nörolojik hastalığın veya rahatsızlığın veya bir viral enfeksiyonun tedavisinde veya önlenmesinde olanı, içeren, terapide kullanımı ile ilgilidir.The invention specifically relates to (hetero) aryl cyclopropylamine compounds comprising compounds of formula I as described and defined herein and their use in therapy, including, for example, in the treatment or prevention of cancer, a neurological disease or disorder, or a viral infection. .
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11382324 | 2011-10-20 | ||
| EP11382329 | 2011-10-27 | ||
| US201161558369P | 2011-11-10 | 2011-11-10 | |
| US201161558370P | 2011-11-10 | 2011-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201903659T4 true TR201903659T4 (en) | 2019-04-22 |
Family
ID=65906343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/03659T TR201903659T4 (en) | 2011-10-20 | 2012-10-22 | (Hetero) aryl cyclopropylamine compounds as LSD1 inhibitors. |
Country Status (10)
| Country | Link |
|---|---|
| CY (1) | CY1121404T1 (en) |
| DK (1) | DK2776394T3 (en) |
| ES (1) | ES2715294T3 (en) |
| HR (1) | HRP20190346T1 (en) |
| HU (1) | HUE041946T2 (en) |
| IL (1) | IL231784B (en) |
| LT (1) | LT2776394T (en) |
| ME (1) | ME03331B (en) |
| PT (1) | PT2776394T (en) |
| TR (1) | TR201903659T4 (en) |
-
2012
- 2012-10-22 ME MEP-2019-50A patent/ME03331B/en unknown
- 2012-10-22 DK DK12787388.3T patent/DK2776394T3/en active
- 2012-10-22 TR TR2019/03659T patent/TR201903659T4/en unknown
- 2012-10-22 PT PT12787388T patent/PT2776394T/en unknown
- 2012-10-22 ES ES12787388T patent/ES2715294T3/en active Active
- 2012-10-22 HU HUE12787388A patent/HUE041946T2/en unknown
- 2012-10-22 HR HRP20190346TT patent/HRP20190346T1/en unknown
- 2012-10-22 LT LTEP12787388.3T patent/LT2776394T/en unknown
-
2014
- 2014-03-27 IL IL231784A patent/IL231784B/en active IP Right Grant
-
2019
- 2019-02-26 CY CY20191100234T patent/CY1121404T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1121404T1 (en) | 2020-05-29 |
| HRP20190346T1 (en) | 2019-04-19 |
| IL231784B (en) | 2019-03-31 |
| ES2715294T3 (en) | 2019-06-03 |
| HUE041946T2 (en) | 2019-06-28 |
| LT2776394T (en) | 2019-04-25 |
| DK2776394T3 (en) | 2019-04-01 |
| ME03331B (en) | 2019-10-20 |
| PT2776394T (en) | 2019-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2014004429A (en) | (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors. | |
| MY187638A (en) | (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors | |
| MX341732B (en) | Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use. | |
| CY1122707T1 (en) | HETEROCYCLIC GLUTAMINASE INHIBITORS | |
| EA201400412A1 (en) | SUBSTITUTED BENZILINDAZOLES FOR USE AS BUB1 INHIBITORS KINAZES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES | |
| EA201591753A1 (en) | 3-PYRIMIDIN-4-ILOXAZOLIDIN-2-ONE AS MUTANT IDH INHIBITORS | |
| PH12014501718A1 (en) | Novel therapeutic agents | |
| EA201591745A1 (en) | 3-PYRIMIDIN-4-IL-OXAZOZOLIDIN-2-ONE AS INHIBITORS MUTANT IDH | |
| EA201490419A1 (en) | COMPOUNDS FOR THE TREATMENT AND PREVENTION OF RESPIRATORY SYNCIAL VIRAL DISEASE | |
| BR112014005468A2 (en) | aminopyridine derivatives for use as modulators of kinase activity | |
| EA201391029A1 (en) | OXAZIN DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF NEUROLOGICAL DISORDERS | |
| EA201590661A1 (en) | AZACHINASOLINE INHIBITORS OF ATYPICAL PROTEINKINASE C | |
| EA201200176A1 (en) | OXAZIN DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
| BR112015009649A2 (en) | triazole compound | |
| MX2013010016A (en) | Alkyne substituted quinazoline compound and methods of use. | |
| MX2014002832A (en) | Novel imidazole amines as modulators of kinase activity. | |
| EA033124B1 (en) | APPLICATION OF A CONDENSED BICYCLIC 2,4-DIAMINOPYRIMIDINE DERIVATIVE FOR TREATMENT OF ALK- OR FAK-MEDIATED DISEASE OR DISORDER IN A SUBJECT | |
| PH12015501038A1 (en) | Inhibitors of iap | |
| EA201600002A1 (en) | DERIVATIVES OF SUBSTITUTED TRIAZOLOPIRIDINES | |
| EA201590415A1 (en) | DERIVATIVES OF DIAZEPINONA APPLICABLE FOR THE TREATMENT OF SYNDROME WITH Fragile X-CHROMOSOME, PARKINSON'S DISEASE OR REFLUX DISEASE | |
| TR201903659T4 (en) | (Hetero) aryl cyclopropylamine compounds as LSD1 inhibitors. | |
| CY1118255T1 (en) | Substituted 6-amino-nicotinamides which carry a group containing KCNQ2 / 3 modulators | |
| MX2013011561A (en) | Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes. | |
| TH162559A (en) | Compound (hetero) aryl Cyclopropyl amine As an inhibitor of LSD1 ((HETERO) ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS). | |
| UA107920C2 (en) | Substituted pyrimidine for the treatment of diseases such as cancer |